showed that allogenic
blood transfusion and the number of units transfused had a significant impact on increasing LOS.
Symptoms are typically present in the first year of life and the disorder is frequently fatal within the first decade of life unless treated with an allogenic
hematopoietic stem cell transplantation.
hematopoietic cell transplantation involves a donor--often, but not exclusively, a family member--who gives the recipient stem cells that reestablish bone marrow production of blood cells and immune function to combat cancer.
BMT can be autologous or allogenic
. Autologous transplants use the patient's own blood cells, while allogenic
transplants use cells from a matched donor.
The patient then underwent high-dose chemotherapy followed by allogenic
stem cell transplantation with stabilization of the disease process.
(30) studied immune reactions of allogenic
adipogenic differentiated ADSCs.
In conjunction, the company's STALIF FLX Integrated Interbody devices offer a unique advantage over other all-titanium implants, as they are indicated for use at one or two contiguous levels with both autograft and/or allogenic
Texas passed a stem cell law which could allow patients to use both autologous and allogenic
stems cells therapeutically (or in FDA parlance, "non-homologously").
Most of these BMTs are autologous (hereditary) but in Pakistan, most of the BMTs are allogenic
(caused by environmental factors).
Following this clinical paradigm, in the present study, we hypothesized that undifferentiated SCMC can repair cartilage lesions in a rabbit model of medial condyle full-thickness lesionsjust as efficient as allogenic
CMV colitis typically occurs in severely immunocompromised patients with AIDS and in those on immunosuppressive agents after allogenic
stem cell transplant or solid organ transplant.
Over the last half-century, allogenic
hematopoietic stem cell transplantation (AHSCT) has evolved from an idea to a well-established therapy used in the treatment of tens of thousands of individuals annually .
ACF offers de novo development, optimisation, qualification, validation, and cGMP-compliant final product and product release testing services for both allogenic
and autologous therapies.
The global stem cell therapy market on the basis of the mode of treatment is segmented into allogenic
and autologous stem cell therapy.
(18) Both established and developing techniques based on the transplantation of cultivated limbal stem or precursor cells have been shown to be useful for the treatment of serious ocular surface diseases, with success rates of approximately 73% for allogenic
and 77% for autologous methods.